News

Sagent’s ciprofloxacin injection will be available immediately in 200mg and 400mg premix bags. Ciprofloxacin injection, USP, is a synthetic broad spectrum antimicrobial agent and is the generic equivalent

Ethics approval was granted on the basis of data generated from previous trials and the first arm of the Phase II trial, which involves the treatment of patients

The test, which is used to monitor treatment efficacy in patients with diabetes, will now be launched into the US marketplace. Assay development involved novel Axis-Shield patented technology

Fosphenytoin sodium injection USP, 50mg PE/mL, is therapeutically equivalent to Parke Davis’s Cerebyx, and is available in two packs: 100mg PE/ 2mL and 500mg PE/10mL single dose vials.

The study will comprise 306 new onset type 1 diabetes patients. Diamyd Medical is planning to file clinical trial applications in another three to four European countries and

Combined with the past FDA clearances for obtaining access, cleaning and shaping, this clearance allows Biolase users to perform the complete root canal procedure using FDA cleared procedures.

Several compounds or new chemical entities (NCEs) from this class lower glucose and improve insulin sensitivity in preclinical models of type 2 diabetes. The patent covers the first

The Trust study is a randomized, multicenter trial of patients with implantable cardioverter defibrillators using Biotronik Lumos and Lumax devices. The Trust study will evaluate the effectiveness of

The entire Phase III program comprised of almost 3000 patients in five studies, the pivotal trial being the largest ever conducted with 1443 patients treated out of 2437